The Lundquist Institute of Biomedical Innovation, Torrance, CA, USA; Department of Pediatrics, Harbor UCLA Medical Center, 1000 W Carson Street, Box 468, Torrance, CA 90509, USA.
Department of Pediatrics, Harbor UCLA Medical Center, 1000 W Carson Street, Box 468, Torrance, CA 90509, USA.
Adv Pediatr. 2024 Aug;71(1):229-240. doi: 10.1016/j.yapd.2024.02.007. Epub 2024 Apr 6.
Pediatric immune thrombocytopenia (ITP) is a fairly common bleeding disorder PRESENTING with a decreased number of platelets. The typical clinical presentation involves mild bleeding symptoms with bruising and petechiae and occasional mucosal bleeding. ITP is thought to be an autoimmune disorder and more recently other mechanisms have been described. Most cases resolve spontaneously and can undergo watchful waiting as the platelet count improves. Initially, steroids or intravenous immunoglobulin G (IVIg) can be used to increase platelets. For those cases that do not resolve and become persistent or chronic, there are multiple treatment options, with new agents being studied in adults that will hopefully make it to clinical trials in pediatrics in the future.
小儿免疫性血小板减少症(ITP)是一种较为常见的出血性疾病,表现为血小板数量减少。典型的临床表现为轻度出血症状,伴有瘀斑和瘀点,偶尔出现黏膜出血。ITP 被认为是一种自身免疫性疾病,最近又描述了其他机制。大多数病例可自发缓解,可以进行观察等待,因为血小板计数会自行改善。最初,可以使用类固醇或静脉注射免疫球蛋白 G(IVIg)来增加血小板。对于那些未缓解且持续或慢性的病例,有多种治疗选择,正在研究成人用的新药物,希望未来能在儿科临床试验中应用。